Stock Scorer

VitaNova Life Sciences Corp (VNOV)

VitaNova Life Sciences Corp reported revenue of 1.8M USD for the quarter ending 30 April 2026, down 8.6% from 2M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 April 2026 1.8M -8.6%
Gross Profit Q2 '26 · ending 30 April 2026 264.7K -77.1%
Operating Income Q2 '26 · ending 30 April 2026 -109.9K -110.2%
Net Income Q2 '26 · ending 30 April 2026 17.5K -97.8%
Cost of Revenue Q2 '26 · ending 30 April 2026 1.5M +91.0%
Operating Cash Flow Q2 '26 · ending 30 April 2026 428.3K -10.6%
Shares Outstanding Q1 '26 · ending 31 January 2026 8.3M -66.7%
EPS Q2 '26 · ending 30 April 2026 -0.00 -113.3%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20262026-04-30 3M3.6K-37.3K—
20252025-04-30 2.7M1.2M850.7K—
20242024-04-30 570.7K205.6K140.9K—
20232023-04-30 38K-24.2K-24.2K—
20222022-04-30 120K-13.4K139.7K—
20212021-04-30 0-52.1K-52.1K—
20202020-04-30 0-72.3K-72.3K—
20192019-04-30 0-71.8K-106.2K—
20182018-04-30 0-48.6K-1.6K—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q4 '262026-04-301.8M
Q3 '262026-01-31709.6K
Q2 '262025-10-31427.1K
Q1 '262025-07-31103.9K
Q4 '252025-04-302M
Q3 '252025-01-31308.3K
Q2 '252024-10-31292.1K
Q1 '252024-07-31108.5K
Q4 '242024-04-30544.6K
Q3 '242024-01-3126.1K
Q2 '242023-10-310
Q1 '242023-07-310
Q4 '232023-04-303K
Q3 '232023-01-3110K
Q2 '232022-10-3110K
Q1 '232022-07-3115K
Q4 '222022-04-3045K
Q3 '222022-01-3130K
Q2 '222021-10-3145K
Q1 '222021-07-310

Gross Profit Quarterly

PeriodEndingGross Profit
Q4 '262026-04-30264.7K
Q3 '262026-01-31316.3K
Q2 '262025-10-31260.8K
Q1 '262025-07-3168.8K
Q4 '252025-04-301.2M
Q3 '252025-01-31189.3K
Q2 '252024-10-31155.8K
Q1 '252024-07-3173.2K
Q4 '242024-04-30351.6K
Q3 '242024-01-3126.1K
Q2 '242023-10-310
Q1 '242023-07-310
Q4 '192019-04-30-5.9K
Q3 '192019-01-310
Q2 '192018-10-315.9K
Q1 '192018-07-310
Q4 '182018-04-30-35.4K
Q3 '182018-01-310
Q2 '182017-10-3119.9K
Q1 '182017-07-3115.5K

Operating Income Quarterly

PeriodEndingOperating Income
Q4 '262026-04-30-109.9K
Q3 '262026-01-3146.7K
Q2 '262025-10-3199.2K
Q1 '262025-07-31-32.4K
Q4 '252025-04-301.1M
Q3 '252025-01-31108.9K
Q2 '252024-10-3162.6K
Q1 '252024-07-31-45.4K
Q4 '242024-04-30232.7K
Q3 '242024-01-315.9K
Q2 '242023-10-31-8.8K
Q1 '242023-07-31-24.2K
Q1 '232022-07-312.1K
Q2 '222021-10-31-30K
Q1 '222021-07-31-10.5K
Q4 '212021-04-30-25.6K
Q3 '212021-01-31-2.9K
Q2 '212020-10-31-12.4K
Q1 '212020-07-31-11.2K
Q4 '202020-04-30-26.3K

Net Income Quarterly

PeriodEndingNet Income
Q4 '262026-04-3017.5K
Q3 '262026-01-31-44.4K
Q2 '262025-10-3135.8K
Q1 '262025-07-31-46.3K
Q4 '252025-04-30800.3K
Q3 '252025-01-3173K
Q2 '252024-10-3132.6K
Q1 '252024-07-31-55.2K
Q4 '242024-04-30167.9K
Q3 '242024-01-315.9K
Q2 '242023-10-31-8.8K
Q1 '242023-07-31-24.2K
Q4 '232023-04-30-4.4K
Q3 '232023-01-31-24.6K
Q2 '232022-10-312.6K
Q1 '232022-07-312.1K
Q3 '222022-01-318.9K
Q2 '222021-10-3115K
Q1 '222021-07-31142.6K
Q4 '212021-04-30-25.6K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q4 '262026-04-301.5M
Q3 '262026-01-31393.3K
Q2 '262025-10-31166.3K
Q1 '262025-07-3135.1K
Q4 '252025-04-30795.8K
Q3 '252025-01-31119K
Q2 '252024-10-31136.3K
Q1 '252024-07-3135.3K
Q4 '242024-04-30193K
Q3 '242024-01-310
Q2 '242023-10-310
Q1 '242023-07-310

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q4 '262026-04-30428.3K
Q3 '262026-01-31-90.4K
Q2 '262025-10-31212.7K
Q1 '262025-07-31263.8K
Q4 '252025-04-30479.1K
Q3 '252025-01-31208.9K
Q2 '252024-10-318.8K
Q1 '252024-07-31-504K
Q4 '242024-04-30-191.2K
Q3 '242024-01-31-150.6K
Q2 '242023-10-31-8K
Q1 '242023-07-31-26.1K
Q4 '232023-04-30-2.3K
Q3 '232023-01-31-28.2K
Q2 '232022-10-315.3K
Q1 '232022-07-316.8K
Q4 '222022-04-30-13.8K
Q3 '222022-01-315.2K
Q2 '222021-10-3119.6K
Q1 '222021-07-31-6.9K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q3 '262026-01-318.3M
Q2 '262025-10-3125M
Q1 '262025-07-3125M
Q3 '252025-01-318.3M
Q2 '252024-10-3125M
Q1 '252024-07-3125M
Q3 '242024-01-316.1M
Q2 '242023-10-315.9M
Q1 '242023-07-315.9M
Q3 '232023-01-315.9M
Q2 '232022-10-315.9M
Q1 '232022-07-315.9M
Q3 '222022-01-315.9M
Q2 '222021-10-315.9M
Q1 '222021-07-315.9M
Q3 '192019-01-315.9M
Q2 '192018-10-315.9M
Q1 '192018-07-315.9M
Q3 '182018-01-315.9M
Q2 '182017-10-314.1M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q4 '262026-04-30-0.00
Q3 '262026-01-310.01
Q2 '262025-10-310.03
Q1 '262025-07-310.03
Q4 '252025-04-300.03
Q3 '252025-01-310.02
Q2 '252024-10-310.01
Q1 '252024-07-310.01
Q4 '242024-04-300.01
Q3 '242024-01-310.00
Q2 '242023-10-310.00
Q1 '242023-07-310.00
Q4 '232023-04-300.00
Q3 '232023-01-310.00
Q2 '232022-10-310.00
Q1 '232022-07-310.00
Q4 '222022-04-300.02
Q3 '222022-01-310.01
Q2 '222021-10-310.01
Q1 '222021-07-310.01